213 related articles for article (PubMed ID: 26933035)
1. Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.
Greifenhagen U; Frolov A; Blüher M; Hoffmann R
J Biol Chem; 2016 Apr; 291(18):9610-6. PubMed ID: 26933035
[TBL] [Abstract][Full Text] [Related]
2. Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients.
Greifenhagen U; Frolov A; Blüher M; Hoffmann R
Anal Bioanal Chem; 2016 Aug; 408(20):5557-66. PubMed ID: 27236317
[TBL] [Abstract][Full Text] [Related]
3. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment.
Jaleel A; Halvatsiotis P; Williamson B; Juhasz P; Martin S; Nair KS
Diabetes Care; 2005 Mar; 28(3):645-52. PubMed ID: 15735202
[TBL] [Abstract][Full Text] [Related]
4. Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus.
Frolov A; Blüher M; Hoffmann R
Anal Bioanal Chem; 2014 Sep; 406(24):5755-63. PubMed ID: 25074545
[TBL] [Abstract][Full Text] [Related]
5. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus.
Kostolanská J; Jakus V; Barák L
J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662
[TBL] [Abstract][Full Text] [Related]
6. Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes.
Chiu CJ; Rabbani N; Rowan S; Chang ML; Sawyer S; Hu FB; Willett W; Thornalley PJ; Anwar A; Bar L; Kang JH; Taylor A
Biofactors; 2018 May; 44(3):281-288. PubMed ID: 29718545
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes.
Heidari F; Rabizadeh S; Rajab A; Heidari F; Mouodi M; Mirmiranpour H; Esteghamati A; Nakhjavani M
Life Sci; 2020 Nov; 260():118422. PubMed ID: 32946914
[TBL] [Abstract][Full Text] [Related]
8. Global proteomic analysis of advanced glycation end products in the
Bilova T; Paudel G; Shilyaev N; Schmidt R; Brauch D; Tarakhovskaya E; Milrud S; Smolikova G; Tissier A; Vogt T; Sinz A; Brandt W; Birkemeyer C; Wessjohann LA; Frolov A
J Biol Chem; 2017 Sep; 292(38):15758-15776. PubMed ID: 28611063
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
[TBL] [Abstract][Full Text] [Related]
10. Identification and relative quantification of specific glycation sites in human serum albumin.
Frolov A; Hoffmann R
Anal Bioanal Chem; 2010 Jul; 397(6):2349-56. PubMed ID: 20496030
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Quantification of Carboxymethyllysine-Modified Peptides in Human Plasma.
Korwar AM; Zhang Q
J Am Soc Mass Spectrom; 2021 Mar; 32(3):744-752. PubMed ID: 33512994
[TBL] [Abstract][Full Text] [Related]
12. Association of plasma proteins at multiple stages of glycation and antioxidant status with erythrocyte oxidative stress in patients with type 2 diabetes.
Tupe RS; Diwan AG; Mittal VD; Narayanam PS; Mahajan KB
Br J Biomed Sci; 2014; 71(3):93-9; quiz 138. PubMed ID: 25265752
[TBL] [Abstract][Full Text] [Related]
13. Long Term Dietary Restriction of Advanced Glycation End-Products (AGEs) in Older Adults with Type 2 Diabetes Is Feasible and Efficacious-Results from a Pilot RCT.
Lotan R; Ganmore I; Shelly S; Zacharia M; Uribarri J; Beisswenger P; Cai W; Troen AM; Schnaider Beeri M
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33076217
[TBL] [Abstract][Full Text] [Related]
14. Poorly controlled type 2 diabetes with no progression of diabetes-related complications and low levels of advanced glycation end products: A Case report.
Nakamura T; Tsujimoto T; Yasuda K; Chujo D; Ohsugi M; Tanabe A; Ueki K; Kajio H
Medicine (Baltimore); 2019 Jul; 98(30):e16573. PubMed ID: 31348288
[TBL] [Abstract][Full Text] [Related]
15. Profile of urinary amino acids and their post-translational modifications (PTM) including advanced glycation end-products (AGEs) of lysine, arginine and cysteine in lean and obese ZSF1 rats.
Baskal S; Büttner P; Werner S; Besler C; Lurz P; Thiele H; Tsikas D
Amino Acids; 2022 Apr; 54(4):643-652. PubMed ID: 34250558
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.
Zhang Q; Monroe ME; Schepmoes AA; Clauss TR; Gritsenko MA; Meng D; Petyuk VA; Smith RD; Metz TO
J Proteome Res; 2011 Jul; 10(7):3076-88. PubMed ID: 21612289
[TBL] [Abstract][Full Text] [Related]
17. Effect of Advanced Glycation End Products on Cognition in Older Adults with Type 2 Diabetes: Results from a Pilot Clinical Trial.
Lotan R; Ganmore I; Livny A; Itzhaki N; Waserman M; Shelly S; Zacharia M; Moshier E; Uribarri J; Beisswenger P; Cai W; Troen AM; Beeri MS
J Alzheimers Dis; 2021; 82(4):1785-1795. PubMed ID: 34250935
[TBL] [Abstract][Full Text] [Related]
18. Sensitive and site-specific identification of carboxymethylated and carboxyethylated peptides in tryptic digests of proteins and human plasma.
Greifenhagen U; Nguyen VD; Moschner J; Giannis A; Frolov A; Hoffmann R
J Proteome Res; 2015 Feb; 14(2):768-77. PubMed ID: 25423611
[TBL] [Abstract][Full Text] [Related]
19. Products of Early and Advanced Glycation in the Soy Milk Proteome.
Milkovska-Stamenova S; Krieg L; Hoffmann R
Mol Nutr Food Res; 2019 Jan; 63(2):e1800725. PubMed ID: 30430721
[TBL] [Abstract][Full Text] [Related]
20. d-Ribose contributes to the glycation of serum protein.
Chen Y; Yu L; Wang Y; Wei Y; Xu Y; He T; He R
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2285-2292. PubMed ID: 31085227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
